SCHEMBL10106338

SCHEMBL10106338

COc1cccc(C(c2cc(C=O)ccc2O)c2cc(C=O)ccc2O)c1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.48
TRIM24 O15164 2/20 0.48
TRIM33 Q9UPN9 2/20 0.48
TDP1 Q9NUW8 2/20 0.48
HPGD P15428 1/20 0.48
ALDH5A1 P51649 1/20 0.48
ABAT P80404 1/20 0.48
ERN1 O75460 1/20 0.44
AOX1 Q06278 1/20 0.44
CHRM2 P08172 1/20 0.43
CHRM1 P11229 1/20 0.43
CHRM3 P20309 1/20 0.43
TYR P14679 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
MAPT P10636 2/20 0.40
TDP2 O95551 1/20 0.40
POLB P06746 1/20 0.40
GAA P10253 1/20 0.40
RAB9A P51151 2/20 0.40
MMP1 P03956 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10145024 0.85 ALDH1A1 (0.42) ALDH1A1TRIM24TRIM33TDP1HPGD
SCHEMBL7074332 0.85 ALDH1A1 (0.51) ALDH1A1TRIM24TRIM33TDP1HPGD
SCHEMBL2730148 0.84 ALDH1A1 (0.54) ALDH1A1TRIM24TRIM33TDP1HPGD
SCHEMBL10145052 0.82 ALDH1A1 (0.41) ALDH1A1TRIM24TRIM33TDP1HPGD
SCHEMBL10106319 0.82 ALDH1A1 (0.45) ALDH1A1TRIM24TRIM33TDP1HPGD
SCHEMBL10106334 0.82 KDM4E (0.43) ALDH1A1TRIM24TRIM33TDP1HPGD
SCHEMBL10106430 0.81 CHRNB2 (0.49) ALDH1A1MAPTKDM4E
SCHEMBL10106351 0.80 ALDH1A1 (0.51) ALDH1A1TRIM24TRIM33TDP1HPGD
SCHEMBL10145050 0.80 ALDH1A1 (0.40) ALDH1A1TRIM24TRIM33TDP1HPGD
SCHEMBL7074379 0.79 KDM4E (0.50) ALDH1A1TRIM24TRIM33TDP1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9321739-B2 Compounds, compositions and methods for treating or preventing pneumovirus infection and associated diseases MICRODOSE THERAPEUTX, INC. (US) 2016-04-26 US disclosed
US-9321739-B2 Compounds, compositions and methods for treating or preventing pneumovirus infection and associated diseases MICRODOSE THERAPEUTX, INC. (US) 2016-04-26 US disclosed
US-8119672-B2 Compounds, compositions and methods for treating or preventing pneumovirus infection and associated diseases MICRODOSE THERAPEUTX, INC. (US) 2012-02-21 US disclosed
US-8119672-B2 Compounds, compositions and methods for treating or preventing pneumovirus infection and associated diseases MICRODOSE THERAPEUTX, INC. (US) 2012-02-21 US disclosed
US-20110305666-A1 COMPOUNDS, COMPOSITIONS AND METHODS FOR TREATING OR PREVENTING PNEUMOVIRUS INFECTION AND ASSOCIATED DISEASES RYS DAVID J (US) 2011-12-15 US disclosed
US-20110305666-A1 COMPOUNDS, COMPOSITIONS AND METHODS FOR TREATING OR PREVENTING PNEUMOVIRUS INFECTION AND ASSOCIATED DISEASES RYS DAVID J (US) 2011-12-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110305666-A1 COMPOUNDS, COMPOSITIONS AND METHODS FOR TREATING OR PREVENTING PNEUMOVIRUS INFECTION AND ASSOCIATED DISEASES TTPA, HAVCR2, PML ALDH1A1 3369/4885TRIM24 2235/4885TRIM33 527/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.